durapatite has been researched along with zidovudine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajpai, PK; Cannon, MR | 1 |
| Bajpai, PK; Billotte, WG; Kreinbrink, K; Odorzynski, A; Reed, D; Rush, BJ | 1 |
| Benghuzzi, H | 1 |
| Goltz, D; Jauch, C; Schott, H; Schott, TC; Schwendener, RA | 1 |
4 other study(ies) available for durapatite and zidovudine
| Article | Year |
|---|---|
Continuous delivery of azidothymidine by hydroxyapatite or tricalcium phosphate ceramics.
Topics: Animals; Calcium Phosphates; Ceramics; Drug Delivery Systems; Durapatite; HIV Infections; Humans; In Vitro Techniques; Materials Testing; Rats; Rats, Sprague-Dawley; Zidovudine | 1995 |
Hydroxyapatite-oil composites for delivering AZT in simulated body fluid.
Topics: Anti-HIV Agents; Biocompatible Materials; Ceramics; Drug Implants; Durapatite; Plant Oils; Reverse Transcriptase Inhibitors; Triticum; Zidovudine | 1997 |
Long-term sustained delivery of 3'-azido-2',3'-dideoxythymidine in vivo by means of HA and TCP delivery devices.
Topics: Animals; Anti-HIV Agents; Calcium Phosphates; Ceramics; Drug Delivery Systems; Drug Implants; Durapatite; Rats; Zidovudine | 2000 |
N⁴-[Alkyl-(hydroxyphosphono)phosphonate]-cytidine-new drugs covalently linking antimetabolites (5-FdU, araU or AZT) with bone-targeting bisphosphonates (alendronate or pamidronate).
Topics: Alendronate; Animals; Antimetabolites, Antineoplastic; Arabinofuranosyluracil; Bone and Bones; Bone Density Conservation Agents; Cell Line, Tumor; Cytidine; Diphosphonates; Drug Screening Assays, Antitumor; Durapatite; Fluorouracil; Humans; Macrophages; Mice; Pamidronate; Uridine; Zidovudine | 2011 |